NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 358 filers reported holding NOVOCURE LTD in Q4 2020. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,741,430 | -61.2% | 541,265 | -0.4% | 0.00% | -50.0% |
| Q2 2023 | $22,545,000 | -30.2% | 543,253 | +1.1% | 0.01% | -40.0% |
| Q1 2023 | $32,311,357 | -17.4% | 537,269 | +0.8% | 0.01% | -23.1% |
| Q4 2022 | $39,113,741 | +0.5% | 533,248 | +4.1% | 0.01% | -7.1% |
| Q3 2022 | $38,931,000 | +10.8% | 512,381 | +1.4% | 0.01% | +16.7% |
| Q2 2022 | $35,124,000 | -13.7% | 505,374 | +2.9% | 0.01% | 0.0% |
| Q1 2022 | $40,706,000 | +12.8% | 491,321 | +2.2% | 0.01% | +9.1% |
| Q4 2021 | $36,098,000 | -33.9% | 480,786 | +2.3% | 0.01% | -38.9% |
| Q3 2021 | $54,611,000 | -61.4% | 470,089 | -26.3% | 0.02% | -61.7% |
| Q2 2021 | $141,551,000 | +72.0% | 638,130 | +2.5% | 0.05% | +56.7% |
| Q1 2021 | $82,282,000 | -17.4% | 622,499 | +8.2% | 0.03% | -25.0% |
| Q4 2020 | $99,590,000 | +53.0% | 575,528 | -1.6% | 0.04% | +33.3% |
| Q3 2020 | $65,110,000 | +2775.9% | 584,934 | +1432.5% | 0.03% | +2900.0% |
| Q2 2020 | $2,264,000 | -82.9% | 38,168 | -80.6% | 0.00% | -87.5% |
| Q1 2020 | $13,278,000 | -20.0% | 197,173 | +0.1% | 0.01% | -11.1% |
| Q4 2019 | $16,593,000 | +14.7% | 196,891 | +1.8% | 0.01% | 0.0% |
| Q3 2019 | $14,469,000 | +29.7% | 193,477 | +9.7% | 0.01% | +28.6% |
| Q2 2019 | $11,155,000 | +56.6% | 176,415 | +19.3% | 0.01% | +40.0% |
| Q1 2019 | $7,125,000 | +49.2% | 147,898 | +3.7% | 0.01% | +25.0% |
| Q4 2018 | $4,777,000 | -34.5% | 142,665 | +2.5% | 0.00% | -20.0% |
| Q3 2018 | $7,293,000 | +74.0% | 139,165 | +3.9% | 0.01% | +66.7% |
| Q2 2018 | $4,192,000 | +87.4% | 133,900 | +30.5% | 0.00% | +50.0% |
| Q1 2018 | $2,237,000 | +11.7% | 102,600 | +3.5% | 0.00% | 0.0% |
| Q4 2017 | $2,002,000 | +3.9% | 99,100 | +2.2% | 0.00% | 0.0% |
| Q3 2017 | $1,926,000 | +14.7% | 97,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $1,679,000 | +163.6% | 97,000 | +23.4% | 0.00% | +100.0% |
| Q1 2017 | $637,000 | +3.1% | 78,600 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $618,000 | -8.0% | 78,600 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $672,000 | -26.8% | 78,600 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $918,000 | +354.5% | 78,600 | +465.5% | 0.00% | – |
| Q1 2016 | $202,000 | -35.0% | 13,900 | 0.0% | 0.00% | – |
| Q4 2015 | $311,000 | – | 13,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $26,344,000 | 8.01% |
| HARTLINE INVESTMENT CORP/ | 318,109 | $23,884,000 | 3.27% |
| Deep Track Capital, LP | 550,000 | $41,294,000 | 2.92% |
| MORGAN JESS S & CO INC | 43,975 | $3,302,000 | 2.03% |
| Taylor Frigon Capital Management LLC | 46,376 | $3,482,000 | 1.09% |
| Darsana Capital Partners LP | 258,937 | $19,441,000 | 0.90% |
| Private Harbour Investment Management & Counsel, LLC | 13,562 | $1,018,000 | 0.81% |
| Rhenman & Partners Asset Management AB | 120,387 | $9,610,000 | 0.64% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $751,000 | 0.50% |
| Baillie Gifford | 9,615,168 | $721,906,000 | 0.40% |